Clinical Trials Logo

Clinical Trial Summary

Systemic autoimmune myopathies are a heterogeneous group of rheumatic diseases that primarily affect the skeletal muscles. The transcranial direct current stimulation technique has been frequent, for example, in patients with ischemic stroke or for the optimization of muscular performance in athletes. However, to date, there are no studies evaluating this technique in patients with systemic autoimmune myopathies. Therefore, the main objective of the present prospective, randomized, double-blind, placebo-controlled study is to evaluate the safety and efficacy of the application of acute transcranial current stimulation session in patients with systemic autoimmune myopathies.


Clinical Trial Description

Currently, there are no studies evaluating the transcranial current stimulation technique in patients with systemic autoimmune myopathies. Therefore, the main objective of the present prospective, randomized, double-blind, placebo-controlled study is to evaluate the safety and efficacy of the application of acute transcranial direct current stimulation session in patients with systemic autoimmune myopathies. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03749538
Study type Interventional
Source University of Sao Paulo
Contact Samuel K Shinjo
Phone 1130617176
Email samuel.shinjo@gmail.com
Status Recruiting
Phase N/A
Start date October 1, 2018
Completion date May 7, 2024

See also
  Status Clinical Trial Phase
Completed NCT04766645 - ACE2 Gender Differences in Stroke With COVID-19
Completed NCT05086809 - Investigation of an Updated Bone-anchored Sound Processor N/A
Completed NCT00070681 - Outcomes of Sleep Disorders in Older Men Phase 3
Terminated NCT00006321 - Neurocognitive Function in Snoring Children N/A
Terminated NCT03270189 - Effect of the Visual Information Change in Functional Dystonia N/A
Completed NCT04422925 - s100β, NSE n GFAP in Living Donor Hepatectomy and Delirium
Suspended NCT04912115 - Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia Phase 2
Completed NCT04568707 - Evaluation of Biological Response to SARS-COV2 (COVID-19) in Patients With Pre-existing Neurological Disease or Newly Neurological Symptoms (BIO-COCO-NEUROSCIENCES) N/A
Completed NCT02605733 - The Neu-Prem Trial: Neuromonitoring of Preterm Newborn Brain During Birth Resuscitation
Recruiting NCT01708668 - The Effects of Intermittent Epidural Bolus on Fever During Labor Analgesia N/A
Completed NCT00006424 - Study of Brain Changes Shaped by Experience N/A
Not yet recruiting NCT06387290 - Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits N/A
Completed NCT02038491 - RICALOR Italian Registry for Complications During Regional Anesthesia N/A
Completed NCT04260035 - The Effects of a Long-lasting Infusion of Vasoactive Intestinal Peptide (VIP) in Episodic Migraine Patients N/A
Terminated NCT03913130 - Extension Study to Study PQ-110-001 (NCT03140969) Phase 1/Phase 2
Completed NCT03471923 - Non-Motor Features of Cervical Dystonia (CD)
Recruiting NCT04855045 - An Open-label, Dose Escalation and Double-masked, Randomized, Controlled Trial Evaluating Safety and Tolerability of Sepofarsen in Children (<8 Years of Age) With LCA10 Caused by Mutations in the CEP290 Gene. Phase 2/Phase 3
Completed NCT02418286 - KLOS Study - Korean Medicine Registry for Low Back Pain Patients, a Prospective, Observational, Multicenter, Pilot Study
Completed NCT05523076 - Transdiagnostic Markers of Cognitive Symptoms in Disorders Affective.
Recruiting NCT05475769 - NUMITOR Study: Nummular Headache Iberian Study on the Treatments and Outcomes in Real-World Setting